CDC Centers for Disease Control and Prevention Public Health &Bioterrorism European Diploma Course in Disaster Medicine Republic of San Marino 12 May,

Slides:



Advertisements
Similar presentations
FHM TRAINING TOOLS This training presentation is part of FHM’s commitment to creating and keeping safe workplaces. Be sure to check out all the training.
Advertisements

Public Health and Healthcare Issues. Public Health and Healthcare.
Responding to the Threat of Bioterrorism: A Status Report on Vaccine Research in the United States Good Morning. Over the next 1 ½ hours of so I’ll be.
BW Agents: Anthrax J.A. Sliman, MD, MPH LCDR MC(FS) USN Preventive Medicine Resident Johns Hopkins Bloomberg School of Public Health.
For Official Use Only. Public Health and EMS How Long Do You Have to Live? For Official Use Only.
Northwest Center for Public Health Practice University of Washington School of Public Health and Community Medicine 1 Preparing for and Responding to Bioterrorism:
BIOLOGICAL AGENTS  CDC has prioritized them in Lists A - C  A List:  Easily transmitted/disseminated  High mortality rate  Potential for public panic.
Bacterial agents of bioterroism. Laboratory network for biological terrorism.
MINISTRY OF HEALTH ACTION PLAN FOR THE PREVENTION AND CONTROL OF ANTHRAX Dr. Marion BullockDuCasse, SMO(H) Director, Emergency, Disaster Management and.
Bioterrorist Agents: Tularemia
Infrastructure and Methods to Support Real Time Biosurveillance Kenneth D. Mandl, MD, MPH Children’s Hospital Boston Harvard Medical School.
Decontamination During Human Biological Incidents Presented by The Ohio Department of Health Disaster Preparedness & Response Program.
Public Health Event Reporting: Lecture Template
Emergency Management Information: Challenges for the 21st Century Emergency Management Information: Challenges for the 21st Century ISCRAM 2008 Washington,
Disease surveillance is an epidemiological practice by which.
ERIC K. NOJI, M.D. Bioterrorism Preparedness European Masters in Disaster Medicine Arona, Italy 27 April 2004 Eric K. Noji, MD, MPH Department of Homeland.
The Science of Agroterrorism Bob L. Larson, DVM, PhD, ACPVM University Extension, Commercial Agriculture Program, Beef Focus Team University of Missouri,
Placing Bioterrorism in its Context Dr. C. de Ville de Goyet.
ANTHRAX By: Justin Tursellino. Anthrax is a…. Anthrax is an infection caused by a bacterium, Bacillus anthracis. The infection can take three forms depending.
Preparing for and Responding to Bioterrorism: Information for the Public Health Workforce *These MS Powerpoint slides and the accompanying instructor’s.
1 Bioterrorism Presentation Sharon F. Grigsby, MBA Executive Director Bioterrorism Preparedness Program Public Health Department of Health Services County.
Anthrax CDC, AFIP. Diseases of Bioterrorist Potential Learning Objectives Describe the epidemiology, mode of transmission and presenting symptoms of disease.
CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION Epidemiology Investigation for Ebola Virus Disease Lei Zhou, MD, Epidemiologist Public Health Emergency.
Role of the laboratory in disease surveillance
Epidemiologic Preparedness and Response to Terrorist Events Involving the Nation’s Food Supply Jeremy Sobel, MD MPH Foodborne and Diarrheal Diseases Branch.
U.S. Surveillance Update Anthony Fiore, MD, MPH CAPT, USPHS Influenza Division National Center for Immunizations and Respiratory Disease Centers for Disease.
Overview of Terrorism Research at the CDC Dixie E. Snider, M.D., MPH. Associate Director for Science Presented at 2003 Medical Research Summit March 6,
27/9/2010Definitions in Epidemiology (Dr. Salwa Tayel) 1.
Notification and Reporting Department of Family and Community Medicine.
JUST-IN-CASE Training for a Public Health Emergency School of Nursing University of Texas at Austin 2011.
Pandemic Influenza Preparedness Kentucky Department for Public Health Department for Public Health.
CHAPTER 25 Epidemiology. Principles of Epidemiology The Science of Epidemiology Epidemiology is the study of disease in populations. To understand infectious.
Bioterrorism MLAB 2434: Microiology Keri Brophy-Martinez.
Bioterrorism Readiness Plan Shands Hospital at the University of Florida 2001.
Northwest Center for Public Health Practice University of Washington School of Public Health and Community Medicine, July 2002 Preparing for and Responding.
Influenza Surveillance at IRID Immunization and Respiratory Infections Division Centre for Infectious Disease Prevention & Control Public Health Agency.
Ohio Department of Health1 The State of Ohio Weapons of Mass Destruction BIO TERRORISM PROTOCOL PROCEDURES FOR LOCAL, STATE AND FEDERAL PERSONNEL AND AGENCIES.
Food Supply Defense Plan: Lessons from Oregon Public Health
CDC Centers for Disease Control and Prevention Medical & Public Health to Bioterrorism: Challenges for Decisive Action 13 th World Congress on Disaster.
Local Emergency Response to Biohazardous Incidents Dr. Elizabeth Whalen, MD Medical Director Albany County Health Department April 8, 2005 Northeast Biological.
Lauren Lewis, MD, MPH Health Studies Branch Environmental Hazards and Health Effects National Center for Environmental Health Centers for Disease Control.
Information Exchange for Detection and Monitoring: Clinical Care to Health Departments Janet J Hamilton, MPH Florida Department of Health.
Responding to SARS John Watson Health Protection Agency Communicable Disease Surveillance Centre, London.
SEARO –CSR Early Warning and Surveillance System Module Case Definitions.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
ERIC K. NOJI, M.D. Bioterrorism Preparedness European Masters in Disaster Medicine Arona, Italy 27 April 2004 Eric K. Noji, MD, MPH Department of Homeland.
Public Health Issues Associated with Biological and Chemical Terrorism Scott Lillibridge, MD Director Bioterrorism Preparedness and Response Activity National.
Public Health Preparedness Summer Institute for Public Health Practice August 4, 2003.
European Masters in Disaster Medicine Sandigliano, Italy 02 May 2005
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 19: Community Preparedness: Disaster and Terrorism.
Promoting Clinician Readiness Maureen Lichtveld, M.D., M.P.H. Associate Director for Workforce Development Public Health Practice Program Office/OD Centers.
SEVERE ACUTE RESPIRATORY SYNDROME – UPDATE Anne-Claire de Benoist and Delia Boccia, European Programme for Intervention.
The Vermont Department of Health Overview of Pandemic Influenza Regional Pandemic Planning Summits 2006 Guidance Support Prevention Protection.
National Governors Association Policy Summit on Domestic Terrorism National Governors Association Policy Summit on Domestic Terrorism Tabletop Exercise.
Assessing Hospital and Health System Preparedness and Response Robert G. Harmon, MD, MPH Vice-President and National Medical Director for Optum/United.
Definitions Learning Objectives At the end of this lecture you (will) be able to: Understand definitions used in infectious disease epidemiology.
UNDERSTANDING BIOTERRORISM: Tara O’Toole, MD, MPH The United States Conference of Mayors Mayors Emergency, Safety & Security Summit October 24, 2001.
Disease Outbreak Maria del Rosario, MD, MPH Infectious Disease Epidemiology Program WVDHHR/BPH/DSDC February
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Is for Epi Epidemiology basics for non-epidemiologists.
C28-A-1 A MODEL RESPONSE TO BIOTERRORISM: Pennsylvania Region 13-WMD Task Force J. David Piposzar, MPH J. David Piposzar, MPH
1 Copyright © 2012 by Mosby, an imprint of Elsevier Inc. Copyright © 2008 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 24 Public Health Surveillance.
Rational Strategies Interventions of choiceInterventions of choice Economic, social and other non-medical countermeasures Interventions of last resortInterventions.
August 2005 EMS & Trauma Systems Section Office of Public Health Preparedness BIOLOGICAL AGENTS.
Bioterrorism Agents Epidemiology Program Overview.
Bioterrorism: A Changing World and What You Can Do
Overview of Terrorism Research at the CDC
Food Supply Defense Plan: Lessons from Oregon Public Health
Bioterrorism.
Dr. Afnan Younis, MPH, SBCM Assistant Professor, Community Medicine
Presentation transcript:

CDC Centers for Disease Control and Prevention Public Health &Bioterrorism European Diploma Course in Disaster Medicine Republic of San Marino 12 May, 2003 Eric K. Noji, M.D., M.P.H. Office of the US Surgeon General US Public Health Service Washington, D.C.

CDC Centers for Disease Control and Prevention

CDC Centers for Disease Control and Prevention

CDC Centers for Disease Control and Prevention Sources of Agents for Terrorism Use World Directory of Collections of Cultures and Microorganisms World Directory of Collections of Cultures and Microorganisms 453 worldwide repositories in 67 nations 453 worldwide repositories in 67 nations 54 ship/sell anthrax 54 ship/sell anthrax 18 ship/sell plague 18 ship/sell plague International black-market sales associated with governmental programs International black-market sales associated with governmental programs

CDC Centers for Disease Control and Prevention

CDC Centers for Disease Control and Prevention Critical Agents B. anthracis (anthrax) B. anthracis (anthrax) Y. pestis (plague) Y. pestis (plague) F. tularensis (tularemia) F. tularensis (tularemia) Filo and Arena viruses (viral hemorrhagic fevers) Filo and Arena viruses (viral hemorrhagic fevers) Cl. botulinum toxin (botulism) Cl. botulinum toxin (botulism) V. major (smallpox) V. major (smallpox)

CDC Centers for Disease Control and Prevention Why These Agents? Infectious via aerosol Infectious via aerosol Organisms fairly stable in aerosol Organisms fairly stable in aerosol Susceptible civilian populations Susceptible civilian populations High morbidity and mortality High morbidity and mortality Person-to-person transmission (smallpox, plague, VHF) Person-to-person transmission (smallpox, plague, VHF) Difficult to diagnose and/or treat Difficult to diagnose and/or treat Previous development for BW Previous development for BW

CDC Centers for Disease Control and Prevention “A bioterrorism attack against Americans anywhere in the world is inevitable in the 21 st century.” Anthony Fauci, Director, NIAID Clinical Infectious Diseases 2001;32:678

CDC Centers for Disease Control and Prevention

CDC Centers for Disease Control and Prevention

CDC Centers for Disease Control and Prevention

CDC Centers for Disease Control and Prevention

Powders, Powders Everywhere… The Impact of the Worried Well on the Public Health System

CDC Centers for Disease Control and Prevention Anthrax: Cutaneous Most common form (95%) Most common form (95%) Inoculation of spores under skin Inoculation of spores under skin Incubation: hours to 7 days Incubation: hours to 7 days Small papule --> ulcer surrounded by vesicles (24-28h) Small papule --> ulcer surrounded by vesicles (24-28h) Painless eschar with edema Painless eschar with edema Death 20% untreated; rare treated Death 20% untreated; rare treated USAMRICD

CDC Centers for Disease Control and Prevention Anthrax: Inhalational Inhalation of spores Inhalation of spores Incubation: 1 to 43 days Incubation: 1 to 43 days Initial symptoms (2-5 d) Initial symptoms (2-5 d) Fever, cough, myalgia, malaise Fever, cough, myalgia, malaise Terminal symptoms (1-2d ) Terminal symptoms (1-2d ) High fever, dyspnea, cyanosis High fever, dyspnea, cyanosis Hemorrhagic mediastinitis/effusion Hemorrhagic mediastinitis/effusion Rapid progression shock/death Rapid progression shock/death Mortality rate ~ 100% despite Rx Mortality rate ~ 100% despite Rx CDC

Centers for Disease Control and Prevention  Detection & surveillance  Rapid laboratory diagnosis  Epidemiologic investigations  Implementation of control measures Public Health Response to Bioterrorism

CDC Centers for Disease Control and Prevention CDC Plague: Bubonic Incubation: 2-6 days Incubation: 2-6 days Sudden onset HA, malaise, myalgia, fever, tender LNs Sudden onset HA, malaise, myalgia, fever, tender LNs Regional lymphadenitis (Buboes) Regional lymphadenitis (Buboes) Cutaneous findings Cutaneous findings possible papule, vesicle, or pustule at inoculation site possible papule, vesicle, or pustule at inoculation site Purpuric lesions - late Purpuric lesions - late

CDC Centers for Disease Control and Prevention

CDC Centers for Disease Control and Prevention

CDC Centers for Disease Control and Prevention

CDC Centers for Disease Control and Prevention

CDC Centers for Disease Control and Prevention BT: Timeliness is the Key to Success Go to the source Go to the source Increase awareness of BT in medical community to improve rapid reporting of: Increase awareness of BT in medical community to improve rapid reporting of: Suspect cases potentially BT-related unusual clusters of disease, in time or space unusual manifestations of disease or unusual disease or symptoms for the geographic area Suspect cases potentially BT-related unusual clusters of disease, in time or space unusual manifestations of disease or unusual disease or symptoms for the geographic area

CDC Centers for Disease Control and Prevention Close Cooperation with clinicians, healthcare and first responder communities Emergency departments, urgent care centers Emergency departments, urgent care centers Infection control units Infection control units Physician networks, private offices Physician networks, private offices Hospitals, HMOs Hospitals, HMOs Medical examiners Medical examiners Poison control Poison control Law enforcement, fire, other first responders Law enforcement, fire, other first responders

CDC Centers for Disease Control and Prevention Clues to Possible Bioterrorism I Single case caused by an uncommon agent Single case caused by an uncommon agent Large number of ill persons with similar disease, syndrome, or deaths Large number of ill persons with similar disease, syndrome, or deaths Large number of unexplained disease, syndrome, or death Large number of unexplained disease, syndrome, or death Unusual illness in a population Unusual illness in a population Higher morbidity & mortality than expected with a common disease or syndrome Higher morbidity & mortality than expected with a common disease or syndrome Multiple disease entities coexisting in the same patient Multiple disease entities coexisting in the same patient Disease with an unusual geographic or seasonal distribution Disease with an unusual geographic or seasonal distribution

CDC Centers for Disease Control and Prevention Clues to Possible Bioterrorism II Multiple atypical presentations of disease agents Multiple atypical presentations of disease agents Similar genetic type of agent from distinct sources Similar genetic type of agent from distinct sources Unusual, atypical, genetically engineered, or antiquated strain Unusual, atypical, genetically engineered, or antiquated strain Endemic disease with unexplained increased incidence Endemic disease with unexplained increased incidence Simultaneous clusters of similar illness in con- contiguous areas Simultaneous clusters of similar illness in con- contiguous areas Atypical aerosol, food, or water transmission Atypical aerosol, food, or water transmission Ill persons presenting during the same time Ill persons presenting during the same time Concurrent animal disease Concurrent animal disease

CDC Centers for Disease Control and Prevention Bioterrorism Surveillance Early, rapid recognition of unusual clinical syndromes or deaths Early, rapid recognition of unusual clinical syndromes or deaths Early rapid recognition of increase above “expected levels” of common syndromes, diseases, or death Early rapid recognition of increase above “expected levels” of common syndromes, diseases, or death

CDC Centers for Disease Control and Prevention Bioterrorism: Potential Data Sources Laboratories Laboratories Infectious disease Infectious disease Specialists Specialists Hospitals Hospitals Physician’s offices Physician’s offices Poison control centers Poison control centers Medical Examiners Death Certificates Police/Fire departments Other “first responders” Pharmacy data

CDC Centers for Disease Control and Prevention

CDC Centers for Disease Control and Prevention Syndrome Surveillance The monitoring of illnesses based upon a constellation of symptoms and/or findings The monitoring of illnesses based upon a constellation of symptoms and/or findings Provides an “early warning system” for outbreaks, emerging pathogens Provides an “early warning system” for outbreaks, emerging pathogens Highly sensitive, seasonal specificity varies Highly sensitive, seasonal specificity varies

CDC Centers for Disease Control and Prevention Release Number of Cases Symptom OnsetSevere Illness Rationale for Syndromic Surveillance

CDC Centers for Disease Control and Prevention Examples of Syndromes for Surveillance Unexplained death w/ history of fever Unexplained death w/ history of fever Meningitis, encephalitis or unexplained acute encephalopathy/delirium Meningitis, encephalitis or unexplained acute encephalopathy/delirium Botulism-like syndrome (cranial nerve impairment and weakness) Botulism-like syndrome (cranial nerve impairment and weakness) Rash and fever Rash and fever Non-pneumonia respiratory tract infection w/ fever Non-pneumonia respiratory tract infection w/ fever Diarrhea/Gastroenteritis Diarrhea/Gastroenteritis Pneumonia Pneumonia Sepsis or non-traumatic shock Sepsis or non-traumatic shock

CDC Centers for Disease Control and Prevention Information System Functions Needed for Bioterrorism Preparedness and Response PREPAREDNESS REQUIRES THAT ALL PARTNERS--LOCAL, STATE, & FEDERAL ARE PART OF SYSTEMS PREPAREDNESS REQUIRES THAT ALL PARTNERS--LOCAL, STATE, & FEDERAL ARE PART OF SYSTEMS Surveillance data analysis--event detection & management Surveillance data analysis--event detection & management Notification—rapid alerting Notification—rapid alerting Communications –information, not data Communications –information, not data Knowledge management Knowledge management

Lessons Learned from Anthrax Incidents Late 2001

CDC Centers for Disease Control and Prevention There Were Some Important Surprises Even for Experts Anthrax lethal dose rates appear to have been seriously over-estimated Anthrax lethal dose rates appear to have been seriously over-estimated Re-aerosolization is a greater problem than anticipated Re-aerosolization is a greater problem than anticipated Dispersal characteristics of an envelope in the mail system could be devastating Dispersal characteristics of an envelope in the mail system could be devastating The threshold at which the medical system will be overwhelmed appears to be lower than expected The threshold at which the medical system will be overwhelmed appears to be lower than expected

CDC Centers for Disease Control and Prevention Varying Presentations of NYC Cutaneous Lesions

CDC Centers for Disease Control and Prevention Effects Magnification Do not need large numbers of casualties to incur massive damage - economic, social, political ! E.g. anthrax by mail: 5 deaths 18 infected 30,000 treated with antibiotics 10,000 treated for 60 days Many billions of dollars cost + impact impact

CDC Centers for Disease Control and Prevention

CDC Centers for Disease Control and Prevention

CDC Centers for Disease Control and Prevention Public Awareness Reliable, credible information to the public is key to keeping cooperation and minimizing panic

CDC Centers for Disease Control and Prevention

CDC Centers for Disease Control and Prevention Decision Making without Data Need to make decisions rapidly in the absence of data Need to make decisions rapidly in the absence of data Access to subject matter experts was limited Access to subject matter experts was limited No “textbook” experience to guide response No “textbook” experience to guide response Understanding of “risk” evolved as outbreak unfolded Understanding of “risk” evolved as outbreak unfolded Need coherent, rapid process for addressing scientific issues in midst of crisis Need coherent, rapid process for addressing scientific issues in midst of crisis

CDC Centers for Disease Control and Prevention TODAY’S SITUATION Many hospitals on trauma diversion with no major incidents going on Many hospitals on trauma diversion with no major incidents going on Not economically viable for hospitals to maintain surge capacity, or even to focus on treating sick and injured (hospitals lose money treating the truly sick) Not economically viable for hospitals to maintain surge capacity, or even to focus on treating sick and injured (hospitals lose money treating the truly sick) Public health infrastructure is beyond simple band-aid fixes Public health infrastructure is beyond simple band-aid fixes Military health system (including VA) is not effectively integrated or used Military health system (including VA) is not effectively integrated or used

CDC Centers for Disease Control and Prevention Provide More Health System Surge Capacity Health care cost control has systematically eliminated reserve capacity from the system. Health care cost control has systematically eliminated reserve capacity from the system. Need to rethink how much surge capacity is needed for emergencies. Need to rethink how much surge capacity is needed for emergencies. Need to re-assess adequacy and geographic extent of mutual aid agreements. Need to re-assess adequacy and geographic extent of mutual aid agreements. What mobile resources can the federal and state governments truly provide? What mobile resources can the federal and state governments truly provide? Also need plans to tap unconventional resources if disasters strike – e.g., sites for emergency care, inventories of health care workers. Also need plans to tap unconventional resources if disasters strike – e.g., sites for emergency care, inventories of health care workers.

CDC Centers for Disease Control and Prevention

CDC Centers for Disease Control and Prevention Epidemiological Pattern of Smallpox Weapon New foci of secondary infection “Contaminated” zone “Infected” zone Zone of initial explosion

CDC Centers for Disease Control and Prevention Summary: Priority Preparedness Activities State & local preparedness planning State & local preparedness planning Surveillance and epidemiology Surveillance and epidemiology Outbreak verification Outbreak verification Laboratory capacity for biologic & chemical agents Laboratory capacity for biologic & chemical agents Health information & communication systems Health information & communication systems Training Training Establish key liaisons Establish key liaisons

CDC Centers for Disease Control and Prevention Bottom Line Early, rapid recognition of unusual clinical syndromes or deaths Early, rapid recognition of unusual clinical syndromes or deaths Early rapid recognition of increase above “expected levels” of common syndromes, diseases, or death Early rapid recognition of increase above “expected levels” of common syndromes, diseases, or death

CDC Centers for Disease Control and Prevention The detection and control of saboteurs are the responsibilities of the FBI, but the recognition of epidemics caused by sabotage is particularly an epidemiologic function…. Therefore, any plan of defense against biological warfare sabotage requires trained epidemiologists, alert to all possibilities and available for call at a moment’s notice anywhere in the country” Alexander Langmuir Founder of CDC EIS Program 1952 CDC Epidemiology and Bioterrorism

U.S. Department of Health and Human Services Eric K. Noji, M.D., M.P.H. Special Assistant to the US Surgeon General for Disaster Medicine, US Public Health Service Phone: Fax: For Questions Contact: